Clinical and diagnostic characteristics of peripheral vasculopathy biomarkers in systemic scleroderma

Journal Title: Серце і судини - Year 2019, Vol 0, Issue 2

Abstract

Vascular lesion is a hallmark of systemic scleroderma (SS). Vasculopathy occurs in every patient with SS. It can be the earliest clinical manifestation or cause the main life‑threatening complications of the disease, and thus determine morbidity and mortality. In SS, progressive vascular damage is characterized by constant activation/damage and apoptosis of endothelial cells, intimal thickening and vasoconstriction, leading to the lumen obliteration. Vascular remodeling leads to a violation of their tone and a decrease in capillary blood flow, followed by tissue ischemia and chronic hypoxia. These phenomena are often accompanied by altered levels of vascular factors. Among the most significant biomarkers of vasculopathy in SS with the greatest evidence base we define anti‑AT1R and anti‑ETAR, soluble intercellular adhesion molecules (sICAM‑1), soluble molecules of adhesion of thrombocyte endothelial cells, placental growth factor (PlGF), pro‑angiogenic angiopoietin‑like protein‑3 (ANGPTL‑3), apelin, chemokines (CXCL5), galectin‑3, E‑selectin, tissue kallikrein, interleukins (IL)‑13 and ‑33, vascular endothelial growth factor (VEGF165b), matrix metalloproteinases‑12, endothelin‑1, nodal adhesion molecules which are associated with the development of either digital ulcers or changes on videocapillaroscopy typical for SS. This shows their active role in the pathogenesis of SS, especially during the disease manifestation. Data is presented on the most significant vascular biomarkers and the main connections between vascular biomarkers and capillaroscopic parameters and/or the presence of digital ulcers in SS. Vascular biomarkers can become prognostic factors of vascular damage at SS, which allows early treatment of vascular complications.

Authors and Affiliations

Ye.  D. Yehudina, I.  Yu. Golovach

Keywords

Related Articles

Infarction mask of aortoarteritis

Arteritis Takayasu (AT) belongs to the group of systemic vasculitis with a predominant lesion of vessels of large diameter. This disease is characterized by granulomatous inflammation of the aorta and its main branches....

Pathogenetic justification and clinical significance of using arginine for prevention of critical ischemia of lower extremities and fatal manifestations of multifocal atherosclerosis

The aim — to investigate the results of treatment with L‑arginine of patients with intermittent claudication for prevention of critical stages of limb ischemia. Materials and methods. 86 patients with intermittent clau...

Influence of unrecovered bloodflow phenomenon in patients with acute myocardial infarction with ST segment elevation after percutaneous coronary intervention on the dynamics of some echocardiography indicators during long-term follow-up

The aim — to determine the effect of unrecovered bloodflow phenomenon (UBF) after percutaneous coronary intervention (PCI) on the dynamics of changes in the end-diastolic index (EDI), end systolic index (ESI) and left ve...

Thrombosis of perforating veins: frequence, structure, features of treatment and connection with cancer

Acute varicose vein thrombosis is one of the main varicose disease complications. It causes deep vein thrombosis in 10 — 25 % and pulmonary embolism — in 10 % of patients. The aim — to study the frequency, nature, distr...

Changes of indices of diurnal blood pressure monitoring under the influence of treatment in patients with essential hypertension complicated with hemorrhagic stroke after early recovery period

The aim — to compare the indices of diurnal blood pressure monitoring (DBPM) in patients with essential hypertension (EH) іn ≥ 6 months after hemorrhagic stroke (HS) before and after treatment with combination of amlodi...

Download PDF file
  • EP ID EP608229
  • DOI 10.30978/HV2019-2-83
  • Views 136
  • Downloads 0

How To Cite

Ye.  D. Yehudina, I.  Yu. Golovach (2019). Clinical and diagnostic characteristics of peripheral vasculopathy biomarkers in systemic scleroderma. Серце і судини, 0(2), 83-92. https://europub.co.uk/articles/-A-608229